The latest headlines across every section, pulled from official and open-access sources.
National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
How the actual number of deaths in England compare with expected numbers for each week.
Summary of norovirus and rotavirus laboratory surveillance and enteric virus outbreaks in England during the 2026 to 2027 season.
The latest report presenting provisional quarterly data on tuberculosis (TB) case notifications and key TB indicators in England. These figures are released for the purpose of providing timely data to inform ongoing TB control activities.
This guidance provides the sources of Shiga toxin-producing Escherichia coli (STEC) infection and guidance on preventing infection.
This evaluation strategy sets out the Department of Health and Social Care's (DHSC) vision for high-quality evaluation of its policies, programmes and projects.
Uninsured patients made up about 1 in 4 of the more than 20,000 gunshot wound inpatient hospitalizations in Florida from 2018 to 2024, an analysis of state data by KFF Health News and The Trace found. They also had shorter hospital stays than those with any form of coverage.
Margaret Hvatum ended up in the hospital after her insurer denied coverage of a medicine she relies on to boost her immune system. Hvatum got entangled in the preapproval process, which the insurance industry has vowed to improve.
Antibiotic use within the NHS is below 2019 pre-pandemic levels but private prescribing increases.
The FDA dealt Lantheus’ bid to garner approval of its radiodiopharmaceutical diagnostic kit a setback due to manufacturing issues at a third-party facility.
As Neuphoria continues to navigate the fallout of its failed social anxiety program, the biotech is mulling an offer from another potential buyer.
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist’s market share with its own next-gen platform.
United Therapeutics has been given a premarket approval from the FDA for its LungFX device.
AstraZeneca has shared the data behind previously disclosed phase 3 rare disease wins, fleshing out the case for a Strensiq successor tipped to generate blockbuster sales. The company has yet to share data from a third trial that missed its primary endpoint.
Ipsen is paying $450 million upfront to buy U.S.-based Kartos Therapeutics for a phase 3-stage blood cancer drug designed to improve Jakafi treatment.
Background: Whether sedative prescriptions after hospital admissions are associated with poor patient outcomes is unknown. We sought to determine the incidence and risk of adverse events associated with sedatives in older adults within 30 days after hospital discharge. Methods: We conducted a population-based cohort study involving older adults (age ≥ 66 yr) discharged alive from hospital in Ontario (2003 to 2023). We assessed the association of sedative prescriptions (benzodiazepines, antidepressant sedatives, or antipsychotics) filled within 7 days after discharge with falls (with or…
In the Original Investigation titled “Pharmacologic Thromboprophylaxis in Medical Inpatients: A Systematic Review and Network Meta-Analysis,” published May 15, 2026, Laura Girardi’s academic degree was incorrectly listed as PhD instead of MD in the author byline. This article has been corrected.
The Original Investigation titled “Bidirectional Association Between Premenstrual Disorders and Psychiatric Disorders,” published on May 8, 2026, was corrected to fix wording in the Abstract Results, which now states that women with PMD were twice as likely as women without PMD to receive a subsequent psychiatric disorder diagnosis. This article was corrected online.
Emergency Medicine
Infectious Diseases